← All candidates
Four insider buys in the last year — $377.5K in all.
5 filings on record.
TLSATiziana Life Sciences Ltd
NasdaqCM · Healthcare · $129.80M
$1.02
+1.91% today
Four insider buys in the last year — $377.5K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 4 buys
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$129.80M
Float
61.9M
49% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Chief Executive Officer
Elrifi Ivor
Bought $237.6K on Aug 5 — 237,616 sh @ $1.00, held indirect, 5.0% of their stake.
No completed positions to measure
10% owner
Cerrone Gabriele M
Bought $41.9K on Jul 21 — 42,357 sh @ $0.9900, held indirect, 0.1% of their stake.
1 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$9.01 avg target
+783.3% vs today · 1 analyst · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Coverage
Tiziana Life Sciences reports reductions in brain inflammation in third MSA patientProactive · 07-31Tiziana Life Sciences doses last patient in Phase 2a multiple sclerosis trialProactive · 06-25Tiziana Life Sciences advances foralumab program with full Phase 2 enrollment and encouraging expanded access data – ICYMIProactive · 05-22Tiziana Life Sciences completes enrollment in Phase 2a multiple sclerosis trialProactive · 05-21
The file stays open
5 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice